Skip to content
Equity News Hub
Equity News Hub

Empowering Investors.

  • Home
  • Auto
  • Jobs
  • Share Market
  • Tech
  • About Us
  • Privacy Policy
  • Disclaimer
  • Fact-Checking Policy
  • Contact
Equity News Hub

Empowering Investors.

Laxmi Dental IPO

Equity News Hub, January 12, 2025

Laxmi Dental Limited, a prominent player in the dental products industry, is set to launch its Initial Public Offering (IPO) on January 13, 2025, with the subscription period closing on January 15, 2025. The company has established a price band of ₹407 to ₹428 per equity share for this offering.

 

🔥 Open Your Hostinger Account Now & Get 20% Off! 🔥

Company Overview

Established in 1989, Laxmi Dental Limited has evolved into an integrated dental products enterprise with a global presence in over 90 countries. The company offers a diverse range of products and services, including custom-made crowns and bridges, branded dental solutions like Illusion Aligners, and pediatric dental products under the Kids-e-Dental brand.

Financial Performance

As one of the top two largest dental laboratories in India by revenue for Fiscal 2023, Laxmi Dental has demonstrated robust financial performance. The company is recognized as the second-largest player in the domestic laboratory business and the largest exporter among Indian dental labs, with a presence in over 95 countries.

Global Presence and Technological Advancements

Laxmi Dental’s commitment to innovation is evident through its adoption of digital dentistry and advanced manufacturing technologies. The company operates state-of-the-art facilities and maintains stringent regulatory compliance to ensure high-quality standards. Its global reach is supported by service hubs in the United States and Europe, catering to a diverse clientele worldwide.

IPO Structure and Objectives

The IPO comprises a fresh issue of equity shares worth ₹138 crore and an Offer for Sale (OFS) of 1.31 crore equity shares, amounting to ₹560 crore, by existing shareholders, including promoters Rajesh Vrajlal Khakhar and Sameer Kamlesh Merchant, as well as OrbiMed Asia II Mauritius Ltd. The primary objectives for raising funds through this IPO include:

  • Debt Repayment: A portion of the proceeds will be allocated to repay existing debts, thereby strengthening the company’s financial position.
  • Capital Expenditure: Investments are planned to enhance production capabilities and technological infrastructure.
  • Subsidiary Investment: Funds will be directed towards Bizdent Devices Pvt Ltd, a subsidiary of Laxmi Dental, to support its growth and expansion initiatives.
  • General Corporate Purposes: Remaining funds will be utilized for various corporate needs to support overall business operations.

 

🔥 Open Your Hostinger Account Now & Get 20% Off! 🔥

 

Anchor Investment

Prior to the public offering, Laxmi Dental successfully raised ₹314 crore from anchor investors, including notable entities such as Aditya Birla Sun Life Mutual Fund, ICICI Prudential Mutual Fund, HDFC Mutual Fund, and the Abu Dhabi Investment Authority.

Laxmi Dental IPO Details

IPO Issue Opening Date: 13th Jan 2025
IPO Issue Closing Date: 15th Jan 2025
IPO Issue Price: ₹407.00-428.00 Per Share
DRHP: Download DRHP
RHP: Download RHP
Anchor List: Download Anchor List
IPO Listing At: BSE, NSE
Retail Quota: Not more than 10% of the Offer
IPO Issue Type: Book Build Issue
IPO Issue Size: ₹698.06 Cr
Offer for Sale: ₹560.06 Cr
Fresh Issue: ₹138.00 Cr
Face Value: ₹2 Per Equity Share
IPO Discount: TBD
Promoter Holding Pre IPO: 46.56%
Promoter Holding Post IPO:

🔥 Open Your Hostinger Account Now & Get 20% Off! 🔥

Laxmi Dental IPO Dates

Latest and updated information on Laxmi Dental IPO. Dates will be updated as they are announced.

IPO Activity Date
IPO Open Date 13-01-2025
IPO Close Date 15-01-2025
Basis of Allotment
Finalisation Date*
16-01-2025
Refunds Initiation* 17-01-2025
Credit of Shares
to Demat Account*
17-01-2025
IPO Listing Date* 20-01-2025

* – Tentative Dates

Laxmi Dental IPO Lots

IPO Activity
Issue Price ₹407.00-428.00
Market Lot: 33 Shares
1 Lot Amount: ₹14124
Min Small HNI Lots(2-10 Lakh): 495 shares (15 lots) – ₹211860
Min Big HNI Lots(10+ Lakh): 2343 shares (71 lots) – ₹1002804

 

Laxmi Dental Limited Financial Information (Restated Consolidated)

Period Ended 30 Sep 2024 31 Mar 2024 31 Mar 2023 31 Mar 2022
Assets 158.22 134.52 96.54 102.75
Revenue 117.9 195.26 163.84 138.07
Profit After Tax 22.74 25.23 -4.16 -18.68
Net Worth 67.09 44.57 19.48 22.94
Total Borrowing 40.91 42.03 31.44 29.63
Amount in ₹ Crore

Laxmi Dental IPO Peer Comparison

The table below show peer comparison from DRHP/RHP.

Company EPS Basic EPS Diluted NAV P/E(x) RoNW Financial statements
Laxmi Dental Limited 4.8 4.8 8.63 78.78
Poly Medicure Ltd. 26.92 26.9 153.22 94.02 19.05

 

Conclusion

Laxmi Dental Limited’s upcoming IPO presents an opportunity for investors to participate in the growth of a leading dental products company with a strong track record, extensive global presence, and commitment to innovation. The funds raised are poised to further enhance the company’s operational capabilities and market reach, positioning it for sustained growth in the dynamic dental industry.

Disclaimer: This blog post is for informational purposes only and should not be construed as financial advice. Potential investors are advised to read the Red Herring Prospectus and consult with financial advisors before making investment decisions.

 

🔥 Open Your Hostinger Account Now & Get 20% Off! 🔥

 

 

Finance Share Market

Post navigation

Previous post
Next post

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Tata Altroz Facelift 2025: A Premium Hatchback Redefined with Style, Safety, and Tech
  • Prostarm Info Systems IPO: Rs. 168 Crore Powerhouse Opens May 27, 2025
  • BEL Secures Rs. 572 Crore Government Orders: A Boost for India’s Defence Innovation
  • Laxmi Dental IPO
  • TCS Declares Interim and Special Dividends for Q3 FY2024-25 . Rs 10 per share as interim dividend and Rs 66 per share as special dividend
©2025 Equity News Hub | WordPress Theme by SuperbThemes